NEUROBO PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.145 USD | +4.14% |
|
-8.09% | -13.97% |
| Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
| Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-18 | 2024-04-19 | 2024-04-22 | 2024-04-23 | 2024-04-24 | |
|---|---|---|---|---|---|
| Last | 3.44 $ | 3.37 $ | 3.12 $ | 3.02 $ | 3.18 $ |
| Volume | 22 788 | 20 562 | 23 389 | 42 194 | 9 792 |
| Change | -0.58% | -2.03% | -7.42% | -3.21% | +4.14% |
| Opening | 3.59 | 3.49 | 3.26 | 3.10 | 2.99 |
| High | 3.59 | 3.49 | 3.30 | 3.19 | 3.5 |
| Low | 3.35 | 3.26 | 3.08 | 2.99 | 2.99 |
Performance
| 1 day | +4.14% | ||
| 1 week | -8.09% | ||
| Current month | -22.25% | ||
| 1 month | -27.48% | ||
| 3 months | +3.59% | ||
| 6 months | -7.56% | ||
| Current year | -13.97% | ||
| 1 year | -42.28% | ||
| 3 years | -99.64% |
Volumes
marketsDaily volume
9 792
Estimated daily volume
167 617
Avg. Volume 20 sessions
24 667
Daily volume ratio
6.80
Avg. Volume 20 sessions USD
77 577.72
Record volume 1
68 515 281
Record volume 2
6 956 098
Record volume 3
6 624 825
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
14 816 216
Net sales (USD)
0
Number of employees
8
Sales / Employee (USD)
0
Free-Float
38.33 %
Free-Float capitalization (USD)
5 679 771
Average Daily Capital Traded
0.52%
Highs and lows
1 week
2.99
3.59
1 month
2.994.60
Current year
2.906.75
1 year
2.896.75
3 years
2.891 576.80
5 years
2.897 200.01
10 years
2.897 200.01
Indicators
Moving average 5 days
3.28
Moving average 20 days
3.77
Moving average 50 days
4.59
Moving average 100 days
4.16
Price spread / (MMA5)
+4.36%
Price spread / (MMA20)
+19.77%
Price spread / (MMA50)
+45.83%
Price spread / (MMA100)
+32.37%
STIM
RSI 9 days
19.27
RSI 14 days
27.64
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.14% | -8.09% | -13.97% | -42.28% | 14.82M | ||
| +0.24% | +3.35% | -0.15% | +22.06% | 105B | ||
| +0.87% | +1.23% | +3.86% | +14.45% | 97.5B | ||
| +1.03% | +3.76% | +2.71% | +0.03% | 22.19B | ||
| +0.50% | +2.50% | -16.09% | -24.26% | 21.33B | ||
| -1.00% | -0.52% | -7.35% | -28.80% | 18.68B | ||
| +1.26% | +3.50% | -41.41% | -44.21% | 16.6B | ||
| +4.04% | +9.65% | -19.83% | -43.82% | 14.52B | ||
| +0.40% | +6.93% | +8.12% | +37.57% | 14.09B | ||
| +1.05% | -0.04% | +22.20% | -6.98% | 10.99B | ||
| -0.22% | -2.88% | -21.18% | -30.32% | 8.63B | ||
| -0.52% | +2.13% | +15.28% | +82.02% | 8.27B | ||
| +0.04% | +1.08% | -0.83% | +44.65% | 7.62B | ||
| +3.20% | +1.02% | +260.83% | +214.81% | 7.16B | ||
| -0.62% | -3.15% | -56.42% | -74.12% | 6.9B | ||
| +0.92% | -2.02% | -20.28% | +73.68% | 6.87B | ||
| Average | +0.95% | -0.65% | +7.22% | +12.16% | ||
| Weighted average by Cap. | +0.66% | +1.26% | +1.64% | +11.02% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
0fa987076c788a2ff8050f8f.Fx7o1D2t4KVMMwFr_Yx_dLaNy1WACArXB6rMNbr9mco.Rn2Om2yAqdU-cEsEt_0QNYf1oTm5TWPvKs76TcyM6IxxK76FcMrT9hNnWA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 09:49:22 am | 3.18 | 500 | 8,199 |
| 09:48:24 am | 3.18 | 100 | 7,699 |
| 09:45:07 am | 3.185 | 100 | 7,599 |
| 09:37:57 am | 3.5 | 5,714 | 7,499 |
| 09:34:35 am | 3.29 | 100 | 1,785 |
| 09:34:35 am | 3.29 | 100 | 1,685 |
Monthly variations
Annual change
| 2024 | -18.30% | ||
| 2023 | -35.60% | ||
| 2022 | -98.04% | ||
| 2021 | -76.76% | ||
| 2020 | -40.00% | ||
| 2019 | 0.00% |
- Stock Market
- Equities
- NRBO Stock
- Quotes NeuroBo Pharmaceuticals, Inc.
